The role of nanotechnologies in diagnostics and treatment of female reproductive system cancer

Introduction . By enhancing detection accuracy, therapeutic effectiveness and minimizing side effects, nanotechnology may contribute to improve diagnostics and treatment of patients with female reproductive system cancer. Aim : to summarize current literature data and assess а role of nanotechnology in treatment of cervical cancer (CC), ovarian cancer (OC), endometrial cancer (EC) and reveal gaps requiring further research. Materials and Methods . The search was carried out in the electronic databases PubMed/MEDLINE, Google Scholar and eLibrary using the following keywords: “gynecological cancer”, “targeted therapy”, “cervical cancer”, “ovarian cancer”, “endometrial cancer”, “nanotechnology”, “nanoparticles”. All works were published between 2011 and 2024. Results . Nanocarrier-based drug delivery systems represent a promising approach to the treatment of female reproductive system oncology, providing precise drug delivery directly to tumor cells. Such systems, including liposomes, nanoparticles, micelles, and dendrimers, are characterized by advanced efficiency, reduced toxicity, as well as the opportunity for controlled release of active components. Nanotechnologies increase the effectiveness of vaccines by prolonging their half-life, affect the СС microenvironment and potentiate the antitumor immune response with minimal toxicity. Nanovaccines are capable of delivering antigens and adjuvants directly to immune cells, enhancing immune response and improving ОС treatment results. Nanotechnologies show prominent potential in improving EC treatment despite that their role in this context remains understudied compared to other types of female reproductive system cancer. Conclusion . Nanoparticles can carry both conventional drugs as well as protein- and nucleic acid-based systems directly to cancer cells. However, only a few nanoparticle-based treatments for female reproductive system cancer have been approved for use. The field is making significant progress toward more effective and widely available treatments.

Authors

Institutions

Publication Details

Journal
Obstetrics Gynecology and Reproduction
Published
2025-04-09
DOI
https://doi.org/10.17749/2313-7347/ob.gyn.rep.2025.617
Citations
2
Primary Topic
Nanoparticles: synthesis and applications
Type
article
Field-Weighted Citation Impact
1.04
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

The role of nanotechnologies in diagnostics and treatment of female reproductive system cancer

Almaz Kh. Islamgulov, E. V. Malikova, Ekaterina Evgenievna Chernaya, Z. R. Faizullina et al.
2 citations
Obstetrics Gynecology and Reproduction
Nanoparticles: synthesis and applications
1.04
article

The role of nanotechnologies in diagnostics and treatment of female reproductive system cancer

Almaz Kh. Islamgulov, E. V. Malikova, Ekaterina Evgenievna Chernaya, Z. R. Faizullina, M. M. Otadzhonov, Kh. A. Merzhoeva, V. A. Glazepa, A. K. Matviets, A. A. Zhilenko, A. I. Tochieva, A. A. Sanova, D. A. Dryaeva, S. Sh. Khaknazarov, T. R. Gazizov
article en
2 citations

Abstract

Introduction . By enhancing detection accuracy, therapeutic effectiveness and minimizing side effects, nanotechnology may contribute to improve diagnostics and treatment of patients with female reproductive system cancer. Aim : to summarize current literature data and assess а role of nanotechnology in treatment of cervical cancer (CC), ovarian cancer (OC), endometrial cancer (EC) and reveal gaps requiring further research. Materials and Methods . The search was carried out in the electronic databases PubMed/MEDLINE, Google Scholar and eLibrary using the following keywords: “gynecological cancer”, “targeted therapy”, “cervical cancer”, “ovarian cancer”, “endometrial cancer”, “nanotechnology”, “nanoparticles”. All works were published between 2011 and 2024. Results . Nanocarrier-based drug delivery systems represent a promising approach to the treatment of female reproductive system oncology, providing precise drug delivery directly to tumor cells. Such systems, including liposomes, nanoparticles, micelles, and dendrimers, are characterized by advanced efficiency, reduced toxicity, as well as the opportunity for controlled release of active components. Nanotechnologies increase the effectiveness of vaccines by prolonging their half-life, affect the СС microenvironment and potentiate the antitumor immune response with minimal toxicity. Nanovaccines are capable of delivering antigens and adjuvants directly to immune cells, enhancing immune response and improving ОС treatment results. Nanotechnologies show prominent potential in improving EC treatment despite that their role in this context remains understudied compared to other types of female reproductive system cancer. Conclusion . Nanoparticles can carry both conventional drugs as well as protein- and nucleic acid-based systems directly to cancer cells. However, only a few nanoparticle-based treatments for female reproductive system cancer have been approved for use. The field is making significant progress toward more effective and widely available treatments.

Obstetrics Gynecology and ReproductionVol. 19(4)
Rostov State Medical University (RU), Ministry of Health of the Russian Federation (RU), North Ossetian State Medical Academy (RU), Bashkir State Medical University (RU), Samara State Medical University (RU), V.I. Vernadsky Crimean Federal University (UA)
Openalex Percentile: Top 26%
Nanoparticles: synthesis and applications
1.04
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.